Did Jim Cramer Nail or Miss These 14 Stocks?

6. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 44

Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company best known for its mRNA-based COVID-19 vaccine. When asked about Moderna back then, Cramer remained supportive:

“I’m a believer in the technology. I want you to stay in it, and if anything, I’d be a buyer under 100. I really do believe in them and their technology.”

Moderna, Inc. (NASDAQ:MRNA) has plummeted 67.64% since that episode, contradicting Cramer’s bullish outlook on the biotech.

Cramer’s comments for the firm in 2025 however have revolved around the firm failing to follow up with similar products. He believes that Moderna, Inc. (NASDAQ:MRNA) has not delivered its promised cancer vaccines, but the firm’s massive cash pile can prove to be the firm’s saving grace. The firm doesn’t generate a profit as it nearly spends all of its revenue on research and development. Here are Cramer’s latest remarks from the 17^th of January:

“No Moderna’s been one of the biggest disappointments of the year. I think, Stephane Bancel, he would be very good more on science, maybe if they had more of a, somewhat CEO in there, that would be terrific.”